Clasificación y tratamiento de los factores de riesgo de accidente cerebrovascular basado en IA (ABSTRACT) estudio de

William Heseltine-Carp1, Aishwarya Kasabe2, Megan Courtman2

  • 1University of Plymouth, School of Medicine, Plymouth, England, UK william.heseltine-carp@plymouth.ac.uk.

PubMed
Resumen

Este estudio desarrolla modelos de inteligencia artificial (IA) para predecir el riesgo de accidente cerebrovascular utilizando datos hospitalarios de rutina. El proyecto de clasificación y tratamiento de factores de riesgo de accidente cerebrovascular basado en IA (ABSTRACT) tiene como objetivo mejorar la identificación y gestión del riesgo de accidente cerebrovascular.

Videos de Conceptos Relacionados

Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
5.4K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.6K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
482